XML 59 R25.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stockholders' Equity (Tables)
6 Months Ended
Dec. 31, 2019
Stockholders' Equity  
Schedule of stock-based compensation expense in the consolidated statements of operations

We recorded stock-based compensation expense in the consolidated statements of operations as follows (in thousands):

Three Months Ended December 31, 

Six Months Ended December 31, 

    

2018

    

2019

    

2018

    

2019

Cost of goods sold

$

150

$

156

$

356

$

328

Selling, general and administrative

7,833

5,548

 

12,945

 

11,633

Research and development

180

140

 

325

 

299

Stock-based compensation expense

$

8,163

$

5,844

$

13,626

$

12,260

Summary of stock option activity

Weighted Average

Weighted-Average

Aggregate

Number of

Exercise

Remaining Contractual

Intrinsic Value

    

Options

    

Price

    

Term

    

(in thousands)

Outstanding at June 30, 2019

 

515,884

$

33.74

Granted

 

Exercised

 

(199,962)

20.16

Expired or forfeited

 

(941)

84.93

Outstanding at December 31, 2019

 

314,981

42.20

 

2.6 years

$

18,438

Exercisable at December 31, 2019

 

296,566

39.98

 

2.3 years

18,019

Summary of RSU award activity

Weighted-

Average

    

Shares

    

Fair Value

Nonvested at June 30, 2019

 

521,140

$

73.97

Granted

 

278,060

87.19

Vested

 

(387,085)

68.56

Forfeited

 

(8,235)

81.90

Nonvested at December 31, 2019

 

403,880

88.09